unknown
Stage
About
Attivare Therapeutics is a preclinical-stage biotechnology company developing biomaterial-based immuno-activating scaffold technology to recruit, reprogram, and release immune cells for cancer and infectious disease applications.
Explore Attivare Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.